Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and ldn-212854

gefitinib has been researched along with ldn-212854 in 1 studies

Compound Research Comparison

Studies
(gefitinib)		Trials
(gefitinib)		Recent Studies (post-2010)
(gefitinib)		Studies
(ldn-212854)		Trials
(ldn-212854)		Recent Studies (post-2010) (ldn-212854)
5,2315662,91912012

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)ldn-212854 (IC50)
Bone morphogenetic protein 4Homo sapiens (human)0.117
ACVR1 proteinHomo sapiens (human)0.026
Bone morphogenetic protein receptor type-1BHomo sapiens (human)0.0929
Bone morphogenetic protein 4Mus musculus (house mouse)0.117
Vascular endothelial growth factor receptor 2Homo sapiens (human)2.04
Bone morphogenetic protein receptor type-1AHomo sapiens (human)0.539
Activin receptor type-1BHomo sapiens (human)4.09
TGF-beta receptor type-1Homo sapiens (human)3.96
Serine/threonine-protein kinase receptor R3Homo sapiens (human)0.0144
TGF-beta receptor type-2Homo sapiens (human)0.327
Activin receptor type-1Homo sapiens (human)0.0262
Bone morphogenetic protein receptor type-2Homo sapiens (human)0.695
5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)2.52

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Canning, P; Choi, S; Cuny, GD; Mohedas, AH; Sanvitale, CE; Wang, Y; Xing, X; Yu, PB1

Other Studies

1 other study(ies) available for gefitinib and ldn-212854

ArticleYear
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
    Journal of medicinal chemistry, 2014, Oct-09, Volume: 57, Issue:19

    Topics: Activin Receptors, Type I; Aminopyridines; Humans; Mutation; Myositis Ossificans; Phenols; Protein Kinase Inhibitors; Structure-Activity Relationship

2014